カテゴリー： QYResearch, 世界, 医療/バイオ

前臨床オンコロジーCROの世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書（QY21JNE2749）
◆英語タイトル：Global Preclinical Oncology CRO Market Size, Status and Forecast 2021-2027
◆商品コード：QY21JNE2749
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2021年6月
◆ページ数：108
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,900 ⇒換算￥444,600見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,850 ⇒換算￥666,900見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,800 ⇒換算￥889,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
本調査資料では、前臨床オンコロジーCROの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（血液がん、固形腫瘍、その他）、用途別市場規模（In Vitro、In Vivo）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・前臨床オンコロジーCROの市場動向
・企業の競争状況、市場シェア
・前臨床オンコロジーCROの種類別市場規模（血液がん、固形腫瘍、その他）
・前臨床オンコロジーCROの用途別市場規模（In Vitro、In Vivo）
・前臨床オンコロジーCROの北米市場規模2016-2027（アメリカ、カナダ）
・前臨床オンコロジーCROの欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・前臨床オンコロジーCROのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・前臨床オンコロジーCROの中南米市場規模2016-2027（メキシコ、ブラジル）
・前臨床オンコロジーCROの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Crown Bioscience、Charles River Laboratory、ICON Plc.、Eurofins Scientific、Taconic Biosciences、Covance、EVOTEC、The Jackson Laboratory、Wuxi AppTec.、MI Bioresearch, Inc.、Champion Oncology, Inc.、Xentech）
・結論
【レポートの概要】

Preclinical research refers to before testing a drug in people, researchers must find out whether it has the potential to cause serious harm, also called toxicity. A Preclinical CRO, or preclinical contract research organization, provides the experience, knowledge, and skill required to take a pharmaceutical product or medical device from the drawing board to distribution. This journey entails a plethora of activities that involve scientists, medical personnel, administrators, governmental and industry liaisons, marketing experts, and a host of other technical and creative individuals. Rarely is this unique combination of credentials and craft already present within a sponsoring organization. The CRO industry emerged to fill this much-needed role, to provide the expertise required to bring a pharmaceutical product or medical device into the marketplace as quickly and smoothly as possible.

Market Analysis and Insights: Global Preclinical Oncology CRO Market
The global Preclinical Oncology CRO market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Preclinical Oncology CRO market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Preclinical Oncology CRO market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Preclinical Oncology CRO market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Preclinical Oncology CRO market.

Global Preclinical Oncology CRO Scope and Market Size
Preclinical Oncology CRO market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Preclinical Oncology CRO market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Blood Cancer
Solid Tumors
Other

Segment by Application
In Vitro
In Vivo

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Crown Bioscience
Charles River Laboratory
ICON Plc.
Eurofins Scientific
Taconic Biosciences
Covance
EVOTEC
The Jackson Laboratory
Wuxi AppTec.
MI Bioresearch, Inc.
Champion Oncology, Inc.
Xentech

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Preclinical Oncology CRO Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Blood Cancer
1.2.3 Solid Tumors
1.2.4 Other
1.3 Market by Application
1.3.1 Global Preclinical Oncology CRO Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 In Vitro
1.3.3 In Vivo
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Preclinical Oncology CRO Market Perspective (2016-2027)
2.2 Preclinical Oncology CRO Growth Trends by Regions
2.2.1 Preclinical Oncology CRO Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Preclinical Oncology CRO Historic Market Share by Regions (2016-2021)
2.2.3 Preclinical Oncology CRO Forecasted Market Size by Regions (2022-2027)
2.3 Preclinical Oncology CRO Industry Dynamic
2.3.1 Preclinical Oncology CRO Market Trends
2.3.2 Preclinical Oncology CRO Market Drivers
2.3.3 Preclinical Oncology CRO Market Challenges
2.3.4 Preclinical Oncology CRO Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Preclinical Oncology CRO Players by Revenue
3.1.1 Global Top Preclinical Oncology CRO Players by Revenue (2016-2021)
3.1.2 Global Preclinical Oncology CRO Revenue Market Share by Players (2016-2021)
3.2 Global Preclinical Oncology CRO Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Preclinical Oncology CRO Revenue
3.4 Global Preclinical Oncology CRO Market Concentration Ratio
3.4.1 Global Preclinical Oncology CRO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Preclinical Oncology CRO Revenue in 2020
3.5 Preclinical Oncology CRO Key Players Head office and Area Served
3.6 Key Players Preclinical Oncology CRO Product Solution and Service
3.7 Date of Enter into Preclinical Oncology CRO Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Preclinical Oncology CRO Breakdown Data by Type
4.1 Global Preclinical Oncology CRO Historic Market Size by Type (2016-2021)
4.2 Global Preclinical Oncology CRO Forecasted Market Size by Type (2022-2027)

5 Preclinical Oncology CRO Breakdown Data by Application
5.1 Global Preclinical Oncology CRO Historic Market Size by Application (2016-2021)
5.2 Global Preclinical Oncology CRO Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Preclinical Oncology CRO Market Size (2016-2027)
6.2 North America Preclinical Oncology CRO Market Size by Type
6.2.1 North America Preclinical Oncology CRO Market Size by Type (2016-2021)
6.2.2 North America Preclinical Oncology CRO Market Size by Type (2022-2027)
6.2.3 North America Preclinical Oncology CRO Market Size by Type (2016-2027)
6.3 North America Preclinical Oncology CRO Market Size by Application
6.3.1 North America Preclinical Oncology CRO Market Size by Application (2016-2021)
6.3.2 North America Preclinical Oncology CRO Market Size by Application (2022-2027)
6.3.3 North America Preclinical Oncology CRO Market Size by Application (2016-2027)
6.4 North America Preclinical Oncology CRO Market Size by Country
6.4.1 North America Preclinical Oncology CRO Market Size by Country (2016-2021)
6.4.2 North America Preclinical Oncology CRO Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Preclinical Oncology CRO Market Size (2016-2027)
7.2 Europe Preclinical Oncology CRO Market Size by Type
7.2.1 Europe Preclinical Oncology CRO Market Size by Type (2016-2021)
7.2.2 Europe Preclinical Oncology CRO Market Size by Type (2022-2027)
7.2.3 Europe Preclinical Oncology CRO Market Size by Type (2016-2027)
7.3 Europe Preclinical Oncology CRO Market Size by Application
7.3.1 Europe Preclinical Oncology CRO Market Size by Application (2016-2021)
7.3.2 Europe Preclinical Oncology CRO Market Size by Application (2022-2027)
7.3.3 Europe Preclinical Oncology CRO Market Size by Application (2016-2027)
7.4 Europe Preclinical Oncology CRO Market Size by Country
7.4.1 Europe Preclinical Oncology CRO Market Size by Country (2016-2021)
7.4.2 Europe Preclinical Oncology CRO Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Preclinical Oncology CRO Market Size (2016-2027)
8.2 Asia-Pacific Preclinical Oncology CRO Market Size by Type
8.2.1 Asia-Pacific Preclinical Oncology CRO Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Preclinical Oncology CRO Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Preclinical Oncology CRO Market Size by Type (2016-2027)
8.3 Asia-Pacific Preclinical Oncology CRO Market Size by Application
8.3.1 Asia-Pacific Preclinical Oncology CRO Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Preclinical Oncology CRO Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Preclinical Oncology CRO Market Size by Application (2016-2027)
8.4 Asia-Pacific Preclinical Oncology CRO Market Size by Region
8.4.1 Asia-Pacific Preclinical Oncology CRO Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Preclinical Oncology CRO Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Preclinical Oncology CRO Market Size (2016-2027)
9.2 Latin America Preclinical Oncology CRO Market Size by Type
9.2.1 Latin America Preclinical Oncology CRO Market Size by Type (2016-2021)
9.2.2 Latin America Preclinical Oncology CRO Market Size by Type (2022-2027)
9.2.3 Latin America Preclinical Oncology CRO Market Size by Type (2016-2027)
9.3 Latin America Preclinical Oncology CRO Market Size by Application
9.3.1 Latin America Preclinical Oncology CRO Market Size by Application (2016-2021)
9.3.2 Latin America Preclinical Oncology CRO Market Size by Application (2022-2027)
9.3.3 Latin America Preclinical Oncology CRO Market Size by Application (2016-2027)
9.4 Latin America Preclinical Oncology CRO Market Size by Country
9.4.1 Latin America Preclinical Oncology CRO Market Size by Country (2016-2021)
9.4.2 Latin America Preclinical Oncology CRO Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Preclinical Oncology CRO Market Size (2016-2027)
10.2 Middle East & Africa Preclinical Oncology CRO Market Size by Type
10.2.1 Middle East & Africa Preclinical Oncology CRO Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Preclinical Oncology CRO Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Preclinical Oncology CRO Market Size by Type (2016-2027)
10.3 Middle East & Africa Preclinical Oncology CRO Market Size by Application
10.3.1 Middle East & Africa Preclinical Oncology CRO Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Preclinical Oncology CRO Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Preclinical Oncology CRO Market Size by Application (2016-2027)
10.4 Middle East & Africa Preclinical Oncology CRO Market Size by Country
10.4.1 Middle East & Africa Preclinical Oncology CRO Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Preclinical Oncology CRO Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Crown Bioscience
11.1.1 Crown Bioscience Company Details
11.1.2 Crown Bioscience Business Overview
11.1.3 Crown Bioscience Preclinical Oncology CRO Introduction
11.1.4 Crown Bioscience Revenue in Preclinical Oncology CRO Business (2016-2021)
11.1.5 Crown Bioscience Recent Development
11.2 Charles River Laboratory
11.2.1 Charles River Laboratory Company Details
11.2.2 Charles River Laboratory Business Overview
11.2.3 Charles River Laboratory Preclinical Oncology CRO Introduction
11.2.4 Charles River Laboratory Revenue in Preclinical Oncology CRO Business (2016-2021)
11.2.5 Charles River Laboratory Recent Development
11.3 ICON Plc.
11.3.1 ICON Plc. Company Details
11.3.2 ICON Plc. Business Overview
11.3.3 ICON Plc. Preclinical Oncology CRO Introduction
11.3.4 ICON Plc. Revenue in Preclinical Oncology CRO Business (2016-2021)
11.3.5 ICON Plc. Recent Development
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Details
11.4.2 Eurofins Scientific Business Overview
11.4.3 Eurofins Scientific Preclinical Oncology CRO Introduction
11.4.4 Eurofins Scientific Revenue in Preclinical Oncology CRO Business (2016-2021)
11.4.5 Eurofins Scientific Recent Development
11.5 Taconic Biosciences
11.5.1 Taconic Biosciences Company Details
11.5.2 Taconic Biosciences Business Overview
11.5.3 Taconic Biosciences Preclinical Oncology CRO Introduction
11.5.4 Taconic Biosciences Revenue in Preclinical Oncology CRO Business (2016-2021)
11.5.5 Taconic Biosciences Recent Development
11.6 Covance
11.6.1 Covance Company Details
11.6.2 Covance Business Overview
11.6.3 Covance Preclinical Oncology CRO Introduction
11.6.4 Covance Revenue in Preclinical Oncology CRO Business (2016-2021)
11.6.5 Covance Recent Development
11.7 EVOTEC
11.7.1 EVOTEC Company Details
11.7.2 EVOTEC Business Overview
11.7.3 EVOTEC Preclinical Oncology CRO Introduction
11.7.4 EVOTEC Revenue in Preclinical Oncology CRO Business (2016-2021)
11.7.5 EVOTEC Recent Development
11.8 The Jackson Laboratory
11.8.1 The Jackson Laboratory Company Details
11.8.2 The Jackson Laboratory Business Overview
11.8.3 The Jackson Laboratory Preclinical Oncology CRO Introduction
11.8.4 The Jackson Laboratory Revenue in Preclinical Oncology CRO Business (2016-2021)
11.8.5 The Jackson Laboratory Recent Development
11.9 Wuxi AppTec.
11.9.1 Wuxi AppTec. Company Details
11.9.2 Wuxi AppTec. Business Overview
11.9.3 Wuxi AppTec. Preclinical Oncology CRO Introduction
11.9.4 Wuxi AppTec. Revenue in Preclinical Oncology CRO Business (2016-2021)
11.9.5 Wuxi AppTec. Recent Development
11.10 MI Bioresearch, Inc.
11.10.1 MI Bioresearch, Inc. Company Details
11.10.2 MI Bioresearch, Inc. Business Overview
11.10.3 MI Bioresearch, Inc. Preclinical Oncology CRO Introduction
11.10.4 MI Bioresearch, Inc. Revenue in Preclinical Oncology CRO Business (2016-2021)
11.10.5 MI Bioresearch, Inc. Recent Development
11.11 Champion Oncology, Inc.
11.11.1 Champion Oncology, Inc. Company Details
11.11.2 Champion Oncology, Inc. Business Overview
11.11.3 Champion Oncology, Inc. Preclinical Oncology CRO Introduction
11.11.4 Champion Oncology, Inc. Revenue in Preclinical Oncology CRO Business (2016-2021)
11.11.5 Champion Oncology, Inc. Recent Development
11.12 Xentech
11.12.1 Xentech Company Details
11.12.2 Xentech Business Overview
11.12.3 Xentech Preclinical Oncology CRO Introduction
11.12.4 Xentech Revenue in Preclinical Oncology CRO Business (2016-2021)
11.12.5 Xentech Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Preclinical Oncology CRO Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Blood Cancer
Table 3. Key Players of Solid Tumors
Table 4. Key Players of Other
Table 5. Global Preclinical Oncology CRO Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Preclinical Oncology CRO Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Preclinical Oncology CRO Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Preclinical Oncology CRO Market Share by Regions (2016-2021)
Table 9. Global Preclinical Oncology CRO Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Preclinical Oncology CRO Market Share by Regions (2022-2027)
Table 11. Preclinical Oncology CRO Market Trends
Table 12. Preclinical Oncology CRO Market Drivers
Table 13. Preclinical Oncology CRO Market Challenges
Table 14. Preclinical Oncology CRO Market Restraints
Table 15. Global Preclinical Oncology CRO Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Preclinical Oncology CRO Market Share by Players (2016-2021)
Table 17. Global Top Preclinical Oncology CRO Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preclinical Oncology CRO as of 2020)
Table 18. Ranking of Global Top Preclinical Oncology CRO Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Preclinical Oncology CRO Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Preclinical Oncology CRO Product Solution and Service
Table 22. Date of Enter into Preclinical Oncology CRO Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Preclinical Oncology CRO Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Preclinical Oncology CRO Revenue Market Share by Type (2016-2021)
Table 26. Global Preclinical Oncology CRO Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Preclinical Oncology CRO Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Preclinical Oncology CRO Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Preclinical Oncology CRO Revenue Market Share by Application (2016-2021)
Table 30. Global Preclinical Oncology CRO Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Preclinical Oncology CRO Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Preclinical Oncology CRO Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Preclinical Oncology CRO Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Preclinical Oncology CRO Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Preclinical Oncology CRO Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Preclinical Oncology CRO Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Preclinical Oncology CRO Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Preclinical Oncology CRO Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Preclinical Oncology CRO Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Preclinical Oncology CRO Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Preclinical Oncology CRO Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Preclinical Oncology CRO Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Preclinical Oncology CRO Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Preclinical Oncology CRO Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Preclinical Oncology CRO Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Preclinical Oncology CRO Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Preclinical Oncology CRO Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Preclinical Oncology CRO Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Preclinical Oncology CRO Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Preclinical Oncology CRO Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Preclinical Oncology CRO Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Preclinical Oncology CRO Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Preclinical Oncology CRO Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Preclinical Oncology CRO Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Preclinical Oncology CRO Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Preclinical Oncology CRO Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Preclinical Oncology CRO Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Preclinical Oncology CRO Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Preclinical Oncology CRO Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Preclinical Oncology CRO Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Preclinical Oncology CRO Market Size by Country (2022-2027) & (US$ Million)
Table 62. Crown Bioscience Company Details
Table 63. Crown Bioscience Business Overview
Table 64. Crown Bioscience Preclinical Oncology CRO Product
Table 65. Crown Bioscience Revenue in Preclinical Oncology CRO Business (2016-2021) & (US$ Million)
Table 66. Crown Bioscience Recent Development
Table 67. Charles River Laboratory Company Details
Table 68. Charles River Laboratory Business Overview
Table 69. Charles River Laboratory Preclinical Oncology CRO Product
Table 70. Charles River Laboratory Revenue in Preclinical Oncology CRO Business (2016-2021) & (US$ Million)
Table 71. Charles River Laboratory Recent Development
Table 72. ICON Plc. Company Details
Table 73. ICON Plc. Business Overview
Table 74. ICON Plc. Preclinical Oncology CRO Product
Table 75. ICON Plc. Revenue in Preclinical Oncology CRO Business (2016-2021) & (US$ Million)
Table 76. ICON Plc. Recent Development
Table 77. Eurofins Scientific Company Details
Table 78. Eurofins Scientific Business Overview
Table 79. Eurofins Scientific Preclinical Oncology CRO Product
Table 80. Eurofins Scientific Revenue in Preclinical Oncology CRO Business (2016-2021) & (US$ Million)
Table 81. Eurofins Scientific Recent Development
Table 82. Taconic Biosciences Company Details
Table 83. Taconic Biosciences Business Overview
Table 84. Taconic Biosciences Preclinical Oncology CRO Product
Table 85. Taconic Biosciences Revenue in Preclinical Oncology CRO Business (2016-2021) & (US$ Million)
Table 86. Taconic Biosciences Recent Development
Table 87. Covance Company Details
Table 88. Covance Business Overview
Table 89. Covance Preclinical Oncology CRO Product
Table 90. Covance Revenue in Preclinical Oncology CRO Business (2016-2021) & (US$ Million)
Table 91. Covance Recent Development
Table 92. EVOTEC Company Details
Table 93. EVOTEC Business Overview
Table 94. EVOTEC Preclinical Oncology CRO Product
Table 95. EVOTEC Revenue in Preclinical Oncology CRO Business (2016-2021) & (US$ Million)
Table 96. EVOTEC Recent Development
Table 97. The Jackson Laboratory Company Details
Table 98. The Jackson Laboratory Business Overview
Table 99. The Jackson Laboratory Revenue in Preclinical Oncology CRO Business (2016-2021) & (US$ Million)
Table 100. The Jackson Laboratory Recent Development
Table 101. Wuxi AppTec. Company Details
Table 102. Wuxi AppTec. Business Overview
Table 103. Wuxi AppTec. Preclinical Oncology CRO Product
Table 104. Wuxi AppTec. Revenue in Preclinical Oncology CRO Business (2016-2021) & (US$ Million)
Table 105. Wuxi AppTec. Recent Development
Table 106. MI Bioresearch, Inc. Company Details
Table 107. MI Bioresearch, Inc. Business Overview
Table 108. MI Bioresearch, Inc. Preclinical Oncology CRO Product
Table 109. MI Bioresearch, Inc. Revenue in Preclinical Oncology CRO Business (2016-2021) & (US$ Million)
Table 110. MI Bioresearch, Inc. Recent Development
Table 111. Champion Oncology, Inc. Company Details
Table 112. Champion Oncology, Inc. Business Overview
Table 113. Champion Oncology, Inc. Preclinical Oncology CRO Product
Table 114. Champion Oncology, Inc. Revenue in Preclinical Oncology CRO Business (2016-2021) & (US$ Million)
Table 115. Champion Oncology, Inc. Recent Development
Table 116. Xentech Company Details
Table 117. Xentech Business Overview
Table 118. Xentech Preclinical Oncology CRO Product
Table 119. Xentech Revenue in Preclinical Oncology CRO Business (2016-2021) & (US$ Million)
Table 120. Xentech Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Preclinical Oncology CRO Market Share by Type: 2020 VS 2027
Figure 2. Blood Cancer Features
Figure 3. Solid Tumors Features
Figure 4. Other Features
Figure 5. Global Preclinical Oncology CRO Market Share by Application: 2020 VS 2027
Figure 6. In Vitro Case Studies
Figure 7. In Vivo Case Studies
Figure 8. Preclinical Oncology CRO Report Years Considered
Figure 9. Global Preclinical Oncology CRO Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Preclinical Oncology CRO Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Preclinical Oncology CRO Market Share by Regions: 2020 VS 2027
Figure 12. Global Preclinical Oncology CRO Market Share by Regions (2022-2027)
Figure 13. Global Preclinical Oncology CRO Market Share by Players in 2020
Figure 14. Global Top Preclinical Oncology CRO Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Preclinical Oncology CRO as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Preclinical Oncology CRO Revenue in 2020
Figure 16. Global Preclinical Oncology CRO Revenue Market Share by Type (2016-2021)
Figure 17. Global Preclinical Oncology CRO Revenue Market Share by Type (2022-2027)
Figure 18. North America Preclinical Oncology CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Preclinical Oncology CRO Market Share by Type (2016-2027)
Figure 20. North America Preclinical Oncology CRO Market Share by Application (2016-2027)
Figure 21. North America Preclinical Oncology CRO Market Share by Country (2016-2027)
Figure 22. United States Preclinical Oncology CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Preclinical Oncology CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Preclinical Oncology CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Preclinical Oncology CRO Market Share by Type (2016-2027)
Figure 26. Europe Preclinical Oncology CRO Market Share by Application (2016-2027)
Figure 27. Europe Preclinical Oncology CRO Market Share by Country (2016-2027)
Figure 28. Germany Preclinical Oncology CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Preclinical Oncology CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Preclinical Oncology CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Preclinical Oncology CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Preclinical Oncology CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Preclinical Oncology CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Preclinical Oncology CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Preclinical Oncology CRO Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Preclinical Oncology CRO Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Preclinical Oncology CRO Market Share by Region (2016-2027)
Figure 38. China Preclinical Oncology CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Preclinical Oncology CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Preclinical Oncology CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Preclinical Oncology CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Preclinical Oncology CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Preclinical Oncology CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Preclinical Oncology CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Preclinical Oncology CRO Market Share by Type (2016-2027)
Figure 46. Latin America Preclinical Oncology CRO Market Share by Application (2016-2027)
Figure 47. Latin America Preclinical Oncology CRO Market Share by Country (2016-2027)
Figure 48. Mexico Preclinical Oncology CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Preclinical Oncology CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Preclinical Oncology CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Preclinical Oncology CRO Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Preclinical Oncology CRO Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Preclinical Oncology CRO Market Share by Country (2016-2027)
Figure 54. Turkey Preclinical Oncology CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Preclinical Oncology CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Preclinical Oncology CRO Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Crown Bioscience Revenue Growth Rate in Preclinical Oncology CRO Business (2016-2021)
Figure 58. Charles River Laboratory Revenue Growth Rate in Preclinical Oncology CRO Business (2016-2021)
Figure 59. ICON Plc. Revenue Growth Rate in Preclinical Oncology CRO Business (2016-2021)
Figure 60. Eurofins Scientific Revenue Growth Rate in Preclinical Oncology CRO Business (2016-2021)
Figure 61. Taconic Biosciences Revenue Growth Rate in Preclinical Oncology CRO Business (2016-2021)
Figure 62. Covance Revenue Growth Rate in Preclinical Oncology CRO Business (2016-2021)
Figure 63. EVOTEC Revenue Growth Rate in Preclinical Oncology CRO Business (2016-2021)
Figure 64. The Jackson Laboratory Revenue Growth Rate in Preclinical Oncology CRO Business (2016-2021)
Figure 65. Wuxi AppTec. Revenue Growth Rate in Preclinical Oncology CRO Business (2016-2021)
Figure 66. MI Bioresearch, Inc. Revenue Growth Rate in Preclinical Oncology CRO Business (2016-2021)
Figure 67. Champion Oncology, Inc. Revenue Growth Rate in Preclinical Oncology CRO Business (2016-2021)
Figure 68. Xentech Revenue Growth Rate in Preclinical Oncology CRO Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed


【免責事項】
https://www.globalresearch.jp/disclaimer
★リサーチレポート[ 前臨床オンコロジーCROの世界市場規模・現状・予測2021年-2027年(Global Preclinical Oncology CRO Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 血液がん遺伝子改変免疫療法の世界市場規模・現状・予測2021年-2027年 Genetic modification immunotherapy for blood cancer is a technique that involves genetic modification of immune system T cells.It allows T cells to recognize weakly expressed antigens in the blood or other organs of the body, such as tumor cells.This form of immunotherapy can be divided into two types: one in which the patient receives genetically modified immune cells from a donor, and the other in which the patient's own immune cells are removed, genetically modified and then given back to the patient.CAR T cell therapy involves genetically altering immune system T cells to produce a protein called CAR or chimeric...
  • 腎臓癌治療の世界市場規模・現状・予測2021年-2027年 Kidney cancer -- also called renal cancer -- is a disease in which kidney cells become malignant (cancerous) and grow out of control, forming a tumor. Almost all kidney cancers first appear in the lining of tiny tubes (tubules) in the kidney. This type of kidney cancer is called renal cell carcinoma. Renal cell carcinoma (RCC) is a common malignant tumor worldwide, referred to as kidney cancer. According to the World Health Organization, the global incidence of kidney cancer accounts for 2% to 3% of systemic tumors. Among malignant tumors of the urinary system, its incidence is second only to...
  • PET/CTシステムの世界市場規模・現状・予測2021年-2027年 Positron emission tomography–computed tomography is a nuclear medicine technique which combines, in a single gantry, a positron emission tomography scanner and an x-ray computed tomography scanner, to acquire sequential images from both devices in the same session, which are combined into a single superposed image. Market Analysis and Insights: Global PET/CT Systems Market The global PET/CT Systems market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities...
  • ロミプロスティムの世界市場規模・現状・予測2021年-2027年 Romiplostim (rINN, USAN) is a fusion protein analog of thrombopoietin, a hormone that regulates platelet production. Market Analysis and Insights: Global Romiplostim Market The global Romiplostim market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Romiplostim market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall...
  • 高親和性神経成長因子受容体の世界市場規模・現状・予測2021年-2027年 Market Analysis and Insights: Global High Affinity Nerve Growth Factor Receptor Market The global High Affinity Nerve Growth Factor Receptor market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global High Affinity Nerve Growth Factor Receptor market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size...
  • 腫瘍バイオマーカーの世界市場規模・現状・予測2021年-2027年 A biomarker is referred to as a traceable biomolecule, whose presence found in body fluids such as blood, serum, urine, and tumor fluid that indicates disease or an underlying condition such as cancer. Market Analysis and Insights: Global Oncology Biomarker Market The global Oncology Biomarker market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oncology Biomarker market to help players in achieving...
  • 腫瘍個別化医療の世界市場規模・現状・予測2021年-2027年 Oncology is a type of medicine that refers to the diagnosis, treatment and prevention of different types of cancers like blood cancer, skin cancer, breast cancer, lung cancer and others. Market Analysis and Insights: Global Personalized Medicines In Oncology Market The global Personalized Medicines In Oncology market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Personalized Medicines In Oncology market to help...
  • イクサベピロンの世界市場規模・現状・予測2021年-2027年 Ixabepilone (INN; also known as azaepothilone B, codenamed BMS-247550) is a pharmaceutical drug developed by Bristol-Myers Squibb as a chemotherapeutic medication for cancer. Market Analysis and Insights: Global Ixabepilone Market The global Ixabepilone market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ixabepilone market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall...
  • 臨床腫瘍学次世代シーケンシングの世界市場規模・現状・予測2021年-2027年 Next generation sequencing (NGS) has created a noteworthy paradigm shift in the clinical diagnostic field. It refers to an aggregate collection of methods in which various sequencing reactions occur at the same time, bringing about vast amounts of sequencing data for a little division of the cost of Sanger sequencing. Market Analysis and Insights: Global Clinical Oncology Next Generation Sequencing Market The global Clinical Oncology Next Generation Sequencing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to...
  • 前臨床光画像の世界市場規模・現状・予測2021年-2027年 Preclinical imaging is the visualization of living animals for research purposes, such as drug development. Imaging modalities have long been crucial to the researcher in observing changes, either at the organ, tissue, cell, or molecular level, in animals responding to physiological or environmental changes. The most used imaging modalities are currently optical (bioluminescence and fluorescence)。 Increasing focus of market players on research and development, strategic collaborations, novel drug development to cater to unmet medical needs, and non-invasive diagnostic techniques is a major factor fueling market growth. Market Analysis and Insights: Global Preclinical Optical Imaging Market The global Preclinical Optical Imaging...
  • 静脈内（IV）鉄投与療法の世界市場規模・現状・予測2021年-2027年 Market Analysis and Insights: Global Intravenous (IV) Iron Therapy Market The global Intravenous (IV) Iron Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Intravenous (IV) Iron Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Intravenous (IV) Iron...
  • 耳がん治療の世界市場規模・現状・予測2021年-2027年 Market Analysis and Insights: Global Ear Cancer Treatment Market The global Ear Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ear Cancer Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Ear Cancer Treatment market in terms...
  • PDXモデルの世界市場規模・現状・予測2021年-2027年 Patient-derived xenografts (PDX) are a model of cancer in which tissues or cells from a patient's tumor are implanted in immunodeficient or humanized mice. The PDX model is used to create an environment that allows the cancer to grow naturally, monitor and evaluate the original patient's treatment accordingly. Market Analysis and Insights: Global PDX Models Market The global PDX Models market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to...
  • 腫瘍臨床試験の世界市場規模・現状・予測2021年-2027年 Clinical trials are the final step in a long process that begins with research in a lab. Oncology trials are predominantly early-phase studies that evaluate surrogate end points and are small, single arm, and open label. Market Analysis and Insights: Global Oncology Clinical Trial Market The global Oncology Clinical Trial market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oncology Clinical Trial...
  • 腎細胞がん治療の世界市場規模・現状・予測2021年-2027年 Renal Cell Cancer Treatment -- also called renal cancer -- is a disease in which kidney cells become malignant (cancerous) and grow out of control, forming a tumor. Almost all kidney cancers first appear in the lining of tiny tubes (tubules) in the kidney. This type of kidney cancer is called renal cell carcinoma. Renal cell carcinoma (RCC) is a common malignant tumor worldwide, referred to as kidney cancer. According to the World Health Organization, the global incidence of kidney cancer accounts for 2% to 3% of systemic tumors. Among malignant tumors of the urinary system, its incidence is second...